Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Tuesday, March 31, 2026.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q1 FY2026 (2026-03-31): -279.27%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-153.74%
RETURN ON EQUITY (ROE) AVG 3Y
-164.59%
RETURN ON EQUITY (ROE) AVG 5Y
-137.69%
RETURN ON EQUITY (ROE) AVG 10Y
-64.05%
RETURN ON EQUITY (ROE) AVG 15Y
-22.67%
RETURN ON EQUITY (ROE) AVG 20Y
-35.66%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
CAMP4 Therapeutics Corporation
Market Cap
$242.85M
Return on Equity (ROE)
N/A
TTM Avg
-153.74%
3Y Avg
-164.59%
5Y Avg
-137.69%
Market Cap
$235.77M
Return on Equity (ROE)
-118.58%
TTM Avg
62.37%
3Y Avg
-376.78%
5Y Avg
-340.60%
Market Cap
$237.27M
Return on Equity (ROE)
-31.55%
TTM Avg
-30.05%
3Y Avg
-33.97%
5Y Avg
-37.95%
Market Cap
$237.74M
Return on Equity (ROE)
N/A
TTM Avg
35.05%
3Y Avg
64.68%
5Y Avg
-167.54%
Market Cap
$232.73M
Return on Equity (ROE)
-25.20%
TTM Avg
-25.82%
3Y Avg
5.12%
5Y Avg
5.12%
Market Cap
$238.61M
Return on Equity (ROE)
-27.27%
TTM Avg
-92.43%
3Y Avg
-64.95%
5Y Avg
-57.80%
Market Cap
$229.14M
Return on Equity (ROE)
-34.04%
TTM Avg
-95.97%
3Y Avg
-70.55%
5Y Avg
-68.40%
Market Cap
$243.64M
Return on Equity (ROE)
-695.56%
TTM Avg
-3698.55%
3Y Avg
-1897.26%
5Y Avg
-1268.80%
Market Cap
$243.81M
Return on Equity (ROE)
N/A
TTM Avg
-1340.59%
3Y Avg
-55.32%
5Y Avg
-61.68%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CAMP4 Therapeutics Corporation (CAMP) | $242.85M | N/A | -153.74% | -164.59% | -137.69% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.77M | -118.58% | 62.37% | -376.78% | -340.60% |
| High Tide Inc. (HITI)vs › | $237.27M | -31.55% | -30.05% | -33.97% | -37.95% |
| Galectin Therapeutics Inc. (GALT)vs › | $237.74M | N/A | 35.05% | 64.68% | -167.54% |
| BioAge Labs Inc. (BIOA)vs › | $232.73M | -25.20% | -25.82% | 5.12% | 5.12% |
| InflaRx N.V. (IFRX)vs › | $238.61M | -27.27% | -92.43% | -64.95% | -57.80% |
| MacroGenics, Inc. (MGNX)vs › | $229.14M | -34.04% | -95.97% | -70.55% | -68.40% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.64M | -695.56% | -3698.55% | -1897.26% | -1268.80% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.81M | N/A | -1340.59% | -55.32% | -61.68% |
| Invivyd, Inc. (IVVD)vs › | $241.61M | -59.27% | -136.66% | -113.26% | -53.68% |
ROE
N/A
ROA
-114.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-03-31 | -279.27% |
| 2025-12-31 | -168.55% |
| 2025-09-30 | -91.02% |
| 2025-06-30 | -129.50% |
| 2025-03-31 | -100.39% |
| 2024-12-31 | -82.02% |
| 2023-08-31 | -270.27% |
| 2023-05-31 | -195.67% |
| 2023-02-28 | -227.09% |
| 2022-11-30 | -179.64% |
| 2022-08-31 | -184.62% |
| 2022-05-31 | -133.67% |
| 2022-02-28 | -37.12% |
| 2021-11-30 | -34.35% |
| 2021-08-31 | -44.05% |
| 2021-05-31 | -45.79% |
| 2021-02-28 | -59.22% |
| 2020-11-30 | -104.12% |
| 2020-08-31 | -73.24% |
| 2020-05-31 | -67.92% |
| 2020-02-29 | -57.50% |
| 2019-11-30 | -6.41% |
| 2019-08-31 | -2.75% |
| 2019-05-31 | 0.60% |
| 2019-02-28 | 8.95% |
| 2018-11-30 | 1.17% |
| 2018-08-31 | 7.01% |
| 2018-05-31 | 13.72% |
| 2018-02-28 | 8.35% |
| 2017-11-30 | 8.90% |
| 2017-08-31 | 2.45% |
| 2017-05-31 | -4.10% |
| 2017-02-28 | -4.36% |
| 2016-11-30 | 1.09% |
| 2016-08-31 | 4.00% |
| 2016-05-31 | 5.41% |
| 2016-02-29 | 8.94% |
| 2015-11-30 | 9.87% |
| 2015-08-31 | 10.26% |
| 2015-05-31 | 10.30% |
| 2015-02-28 | 10.90% |
| 2014-11-30 | 9.10% |
| 2014-08-31 | 9.57% |
| 2014-05-31 | 9.35% |
| 2014-02-28 | 8.86% |
| 2013-11-30 | 32.38% |
| 2013-08-31 | 33.99% |
| 2013-05-31 | 35.13% |
| 2013-02-28 | 37.96% |
| 2012-11-30 | 34.67% |
| 2012-08-31 | 32.84% |
| 2012-05-31 | 29.57% |
| 2012-02-28 | 20.89% |
| 2011-11-26 | 17.10% |
| 2011-08-27 | 9.83% |
| 2011-05-28 | -1.54% |
| 2011-02-28 | -18.65% |
| 2010-08-28 | -36.96% |
| 2010-05-29 | -54.52% |
| 2010-02-28 | -56.52% |
| 2009-11-28 | -364.99% |
| 2009-08-29 | -351.03% |
| 2009-05-30 | -267.01% |
| 2009-02-28 | -214.08% |
| 2008-11-29 | -19.37% |
| 2008-08-30 | -99.25% |
| 2008-05-31 | -100.69% |
| 2008-03-01 | -114.61% |
| 2007-12-01 | -92.97% |
| 2007-09-01 | -10.26% |
| 2007-06-02 | -6.02% |
| 2007-03-03 | -20.62% |
| 2006-11-30 | -19.01% |
| 2006-08-31 | -16.19% |
| 2006-05-31 | -14.73% |
| 2006-02-28 | 8.27% |
| 2005-11-30 | 8.37% |
| 2005-08-31 | 6.51% |
| 2005-05-31 | 5.46% |
| 2005-02-28 | 5.10% |
| 2004-11-30 | 5.06% |
| 2004-08-31 | 6.21% |
| 2004-05-31 | 5.41% |
| 2004-02-28 | 8.74% |
| 2003-11-30 | 5.99% |
| 2003-08-31 | 2.01% |
| 2003-05-31 | 4.51% |
